LINDA SKALSKY: Open Payments
NPI 1194837989 · GAINESVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$17,431 in 132 payments from 10 companies in 2025. Trend: 2023 $16,051 · 2024 $5,663 · 2025 $17,431
Speaker / faculty: $9,530Consulting: $3,875Food & beverage: $2,543Travel & lodging: $1,483
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 32 | $9,982 |
| ABBVIE INC. | 29 | $6,077 |
| Vanda Pharmaceuticals Inc. | 15 | $365 |
| Teva Pharmaceuticals USA, Inc. | 19 | $313 |
| Alkermes, Inc. | 14 | $228 |
| E.R. Squibb & Sons, L.L.C. | 10 | $178 |
| Neurocrine BioSciences, Inc. | 7 | $169 |
| Axsome Therapeutics, Inc. | 3 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $48 |
| Indivior Inc. | 1 | $21 |
Products named: CAPLYTA, VRAYLAR, FANAPT, UZEDY, COBENFY, INGREZZA, ARISTADA, LYBALVI.
Industry payments across FL — which companies pay providers there.
